Inactive Instrument

NuVasive, Inc.

Equities

NUVA

US6707041058

Medical Equipment, Supplies & Distribution

NuVasive, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022

February 23, 2023 at 02:47 am IST

NuVasive, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 1,201.94 million compared to USD 1,138.99 million a year ago. Net income was USD 40.41 million compared to net loss of USD 64.09 million a year ago.

Basic earnings per share from continuing operations was USD 0.78 compared to basic loss per share from continuing operations of USD 1.24 a year ago. Diluted earnings per share from continuing operations was USD 0.76 compared to diluted loss per share from continuing operations of USD 1.24 a year ago.

Latest news about NuVasive, Inc.

Globus Medical Launches Precice Bone Transport in Select Markets	07/23/07	MT
NuVasive, Inc.(NasdaqGS:NUVA) dropped from NASDAQ Composite Index	04/23/04	CI
Globus Medical Completes Merger With NuVasive	01/23/01	MT
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P 600 Health Care	01/23/01	CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P 600	01/23/01	CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P Healthcare Equipment Select Industry Index	01/23/01	CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P Composite 1500	01/23/01	CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P TMI Index	01/23/01	CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P 1000	01/23/01	CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P Global BMI Index	01/23/01	CI
Globus Medical, Inc. completed the acquisition of NuVasive, Inc. from BlackRock, Inc., The Vanguard Group, Inc., Thrivent Financial for Lutherans and others for $2.6 billion.	01/23/01	CI
Goosehead Insurance, Jackson Financial Advance Amid Addition to S&P SmallCap 600	29/23/29	MT
Goosehead Insurance, Jackson Financial to be Added to S&P SmallCap 600	29/23/29	MT
Barclays Adjusts Price Target on NuVasive to $58 From $56, Maintains Overweight Rating	04/23/04	MT
Transcript : NuVasive, Inc., Q2 2023 Earnings Call, Aug 02, 2023	03/23/03
Earnings Flash (NUVA) NUVASIVE Reports Q2 Revenue $317.8M, vs. Street Est of $323.1M	03/23/03	MT
Earnings Flash (NUVA) NUVASIVE Reports Q2 EPS $0.56, vs. Street Est of $0.55	03/23/03	MT
NuVasive, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	03/23/03	CI
NuVasive, Inc. Provides Sales Guidance for the Full Year 2023	03/23/03	CI
Truist Securities Adjusts Price Target on NuVasive to $51 From $48, Maintains Hold Rating	19/23/19	MT
NuVasive, Inc.(NasdaqGS:NUVA) added to Russell Small Cap Comp Value Index	23/23/23	CI
NuVasive, Inc.(NasdaqGS:NUVA) added to Russell 2000 Value-Defensive Index	23/23/23	CI
NuVasive, Inc.(NasdaqGS:NUVA) added to Russell 3000E Value Index	23/23/23	CI
NuVasive, Inc.(NasdaqGS:NUVA) added to Russell 2500 Value Index	23/23/23	CI
NuVasive, Inc.(NasdaqGS:NUVA) added to Russell 2000 Value Index	23/23/23	CI

Chart NuVasive, Inc.

Duration

Period

More charts

Company Profile

NuVasive, Inc. is a medical technology company. The Company is focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. It offers a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, it develops and sells magnetically adjustable implant systems for the spine and specialized orthopedic procedures. It also designs and sell expandable growing rod implant systems for the treatment of early-onset scoliosis that can be non-invasively lengthened after implantation with incremental adjustments via an external remote controller using magnetic technology called MAGneticExternal Control (MAGEC). It operates in more than 50 countries serving surgeons, hospitals, and patients.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-4.84%	182B
MEDTRONIC PLC	+0.56%	110B
BECTON, DICKINSON AND COMPANY	-3.35%	68.11B
DEXCOM, INC.	+2.39%	50.53B
CENCORA, INC.	+9.36%	44.8B
HOYA CORPORATION	+2.70%	40.7B
METTLER-TOLEDO INTERNATIONAL, INC.	+24.51%	32.3B
WEST PHARMACEUTICAL SERVICES, INC.	+3.43%	26.53B
TERUMO CORPORATION	+13.67%	25.02B

Other Medical Equipment, Supplies & Distribution